What causes excessive dandruff?
Excessive dandruff—clinically referred to as severe or persistent scaling of the scalp—is commonly caused by a combination of factors involving skin cell turnover, microbial activity, and individual susceptibility. The most frequent underlying cause is seborrheic dermatitis, a chronic inflammatory condition linked to an overgrowth of *Malassezia* yeast species (particularly *Malassezia globosa* and *M. restricta*) on the scalp surface. These commensal fungi metabolize sebum into irritating fatty acids (e.g., oleic acid), which disrupt the epidermal barrier and accelerate keratinocyte proliferation—leading to visible flaking, pruritus, and erythema.
Other important contributors include psoriasis, which presents with well-demarcated, thick, silvery-white plaques due to dysregulated keratinocyte differentiation and immune-mediated inflammation; contact dermatitis from hair care products containing irritants or allergens (e.g., fragrances, sulfates, or preservatives); and less commonly, fungal infections such as tinea capitis—especially in children—or secondary bacterial colonization in compromised skin. Underlying systemic conditions—including HIV infection, Parkinson’s disease, depression, and immunosuppression—can exacerbate dandruff severity by altering immune surveillance or sebum composition.
Lifestyle and environmental factors also play a role: infrequent shampooing allows scale accumulation; excessive use of styling products can occlude follicles and promote microbial growth; cold, dry weather may worsen transepidermal water loss; and psychological stress has been shown to upregulate pro-inflammatory cytokines and sebaceous gland activity. Diagnosis relies on clinical evaluation—distinguishing features such as scale morphology, distribution, associated erythema, and presence of lesions elsewhere—and occasionally dermoscopy or scalp biopsy in atypical or treatment-resistant cases.
Effective management involves targeted antifungal shampoos (e.g., ketoconazole 1–2%, ciclopirox, selenium sulfide 2.5%), keratolytic agents (salicylic acid, coal tar), and anti-inflammatory options (low-potency topical corticosteroids or calcineurin inhibitors). Long-term control often requires regular maintenance therapy and avoidance of known triggers. Persistent or worsening symptoms warrant dermatologic evaluation to rule out mimics and optimize personalized treatment.